content

Chugai Files for Additional Indications of Antibody Cocktail Ronapreve for Prophylaxis of COVID-19 and Treatment of Asymptomatic COVID-19

Chugai Pharmaceutical Co., Ltd. announced that it filed an application with the Ministry of Health, Labour and Welfare (MHLW) for approval of additional indications...

Bharat Biotech’s Covaxin granted emergency use approval for kids aged 2-18 years

The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Hyderabad-based Bharat...

Brii Bio Initiates Submission of EUA Filing to U.S. FDA for BRII-196/BRII-198, , its Monoclonal Antibody Combination Therapy for Non-Hospitalized COVID-19 Patients

Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced the filing...

Glenmark launches Tavulus for COPD treatment in Spain, becoming one of the first companies to launch a bioequivalent version of the dry powder inhaler

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under...

Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups

Sweden and Denmark said they are pausing the use of Moderna's (MRNA.O) COVID-19 vaccine for younger age groups after reports of possible rare cardiovascular...

Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced it will build a state-of-the-art mRNA facility in Africa with the...

Etihad Cargo Expands its African Footprint with the Signing of Pharma Agreement with Astral Aviation and Kenya Airways

Etihad Cargo, the cargo and logistics arm of Abu Dhabiโ€™s Etihad Aviation Group, has expanded its pharma sector reach into Africa with the signing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read